Amphotericin B deoxycholate (AmBD) was introduced 45 years ago for the treatment of invasive mycoses, on the basis of open-label non comparative data. Throughout these years of use it proved to be a life-saving drug but also a toxic compound which under current approval criteria might not meet licen
β¦ LIBER β¦
Amphotericin B lipid preparations: what are the differences?
β Scribed by J. P. Adler-Moore; R. T. Proffitt
- Book ID
- 111109302
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 112 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1198-743X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Lipid formulations of amphotericin B: wh
β
A. Antoniadou; B. Dupont
π
Article
π
2005
π
Masson Editeur
π
French
β 206 KB
Effect of nystatin, amphotericin B and a
β
Maria Aperecida Resende; FlΓ‘vio Alterhum
π
Article
π
1990
π
Springer Netherlands
π
English
β 636 KB
Saccharomyces cerevisiae was cultured under anaerobiosis in semi-complete medium to which either palmitoleic or oleic acid was added. Cells were grown at 20 degrees C or 30 degrees C. The levels of total lipids, total sterols, and phospholipids were higher in cells grown at 20 degrees C than at 30 d
What are the differences?
β
Volker Weidmann
π
Article
π
2011
π
Vieweg Verlag
π
English
β 624 KB
Effect of amphotericin B on the lipids o
β
Sarah Piancastelli Franzot; JΓΊnia Soares Hamdan
π
Article
π
1994
π
Springer Netherlands
π
English
β 437 KB
The efficacy of two different lipid-base
β
Hasan Cetin; Mehmet Yalaz; Mete Akisu; Suleyha Hilmioglu; Dilek Metin; Nilgun Ku
π
Article
π
2005
π
John Wiley and Sons
π
English
β 86 KB
Do variations in molecular structure aff
β
Jayesh Mehta
π
Article
π
1997
π
Elsevier Science
π
English
β 659 KB